Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

Background and purpose: Temporary discontinuation of natalizumab is sometimes considered as the observed risk of progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS). However, interruption of natalizumab may result in a re‐start of disease activity. Methods: In...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of neurology Ročník 19; číslo 5; s. 783 - 787
Hlavní autoři:	Borriello, G., Prosperini, L., Mancinelli, C., Giannì, C., Fubelli, F., Pozzilli, C.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford, UK Blackwell Publishing Ltd 01.05.2012 John Wiley & Sons, Inc
Témata:	Adult Antibodies, Monoclonal, Humanized - therapeutic use Clinical trials Disability Evaluation Drugs Female Humans Immunologic Factors - therapeutic use Intravenous administration Magnetic Resonance Imaging Male Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Natalizumab observational study Product Surveillance, Postmarketing Progressive multifocal leukoencephalopathy Prospective Studies rebound Retrospective Studies Risk assessment Severity of Illness Index Statistics, Nonparametric Steroid hormones Steroids
ISSN:	1351-5101, 1468-1331, 1468-1331
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!